Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Murrell

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Journal of Neurovirology|October 3, 2015
Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infectionJosué Pérez-Santiago, Rachel D Schrier, Michelli F de Oliveira, et al.
Nature Communications|January 11, 2022
A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivoLeo Hanke, Hrishikesh Das, Daniel J Sheward, et al.
Elife|January 17, 2019
Reprogramming the antigen specificity of B cells using genome-editing technologiesJames E Voss, Alicia Gonzalez-Martin, Raiees Andrabi, et al.
Nature Communications|June 18, 2021
Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2Niclas Roxhed, Annika Bendes, Matilda Dale, et al.
Nature Communications|December 8, 2020
Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cellsDeli Huang, Jenny Tuyet Tran, Alex Olson, et al.
Nature Communications|November 18, 2020
Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cellsDeli Huang, Jenny Tuyet Tran, Alex Olson, et al.
Cell Reports. Medicine|May 18, 2024
Structural basis of broad SARS-CoV-2 cross-neutralization by affinity-matured public antibodiesDaniel J Sheward, Pradeepa Pushparaj, Hrishikesh Das, et al.
Nature Communications|November 5, 2020
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2Tânia F Custódio, Hrishikesh Das, Daniel J Sheward, et al.
Ebiomedicine|September 10, 2022
Protection against SARS-CoV-2 transmission by a parenteral prime-Intranasal boost vaccine strategyDennis Christensen, Charlotta Polacek, Daniel J Sheward, et al.
Nature Communications|July 27, 2024
Multi-compartmental diversification of neutralizing antibody lineages dissected in SARS-CoV-2 spike-immunized macaquesMarco Mandolesi, Hrishikesh Das, Liset de Vries, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Journal of Neurovirology|October 3, 2015
Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infectionJosué Pérez-Santiago, Rachel D Schrier, Michelli F de Oliveira, et al.
Nature Communications|January 11, 2022
A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivoLeo Hanke, Hrishikesh Das, Daniel J Sheward, et al.
Elife|January 17, 2019
Reprogramming the antigen specificity of B cells using genome-editing technologiesJames E Voss, Alicia Gonzalez-Martin, Raiees Andrabi, et al.
Nature Communications|June 18, 2021
Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2Niclas Roxhed, Annika Bendes, Matilda Dale, et al.
Nature Communications|December 8, 2020
Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cellsDeli Huang, Jenny Tuyet Tran, Alex Olson, et al.
Nature Communications|November 18, 2020
Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cellsDeli Huang, Jenny Tuyet Tran, Alex Olson, et al.
Cell Reports. Medicine|May 18, 2024
Structural basis of broad SARS-CoV-2 cross-neutralization by affinity-matured public antibodiesDaniel J Sheward, Pradeepa Pushparaj, Hrishikesh Das, et al.
Nature Communications|November 5, 2020
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2Tânia F Custódio, Hrishikesh Das, Daniel J Sheward, et al.
Ebiomedicine|September 10, 2022
Protection against SARS-CoV-2 transmission by a parenteral prime-Intranasal boost vaccine strategyDennis Christensen, Charlotta Polacek, Daniel J Sheward, et al.
Nature Communications|July 27, 2024
Multi-compartmental diversification of neutralizing antibody lineages dissected in SARS-CoV-2 spike-immunized macaquesMarco Mandolesi, Hrishikesh Das, Liset de Vries, et al.
Pageof 12